Medicare Enrolled
Dr. Shadi Qasqas, M.D.
Cardiovascular Disease · Rancho Cucamonga, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Qasqas from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Qasqas?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Qasqas
Dr. Shadi Qasqas is a cardiovascular disease specialist in Rancho Cucamonga, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Qasqas performed 7,706 Medicare services across 2,536 unique beneficiaries.
Between the years covered by Open Payments, Dr. Qasqas received a total of $7,877 from 36 pharmaceutical and/or device companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Qasqas is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 18 years in practice
▲ Top 10% volume in CA
$7,877 industry payments
Medicare Practice Summary
Medicare Utilization ↗7,706
Medicare services
Top 10% in CA for cardiovascular disease
2,536
Unique beneficiaries
$80
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~428 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
2,874 | $64 | $380 |
| Hospital follow-up visit, high complexity Subsequent hospital inpatient or observation care for an existing patient involving high-level medical decision making, with at least 50 minutes total time on the date of the encounter. |
1,697 | $95 | $550 |
| Electrocardiogram (EKG), 12-lead A standard heart rhythm test using at least 12 leads to record electrical activity. A healthcare provider interprets the results and provides a written report. |
586 | $11 | $95 |
| Initial hospital admission, high complexity Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter. |
531 | $133 | $1,060 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
491 | $94 | $574 |
| Anticoagulant management for warfarin Management of anticoagulant therapy for a patient taking warfarin. This service involves monitoring and adjusting the medication regimen. |
291 | $9 | $65 |
| Critical care, first 30-74 min Emergency medical care for a critically ill or injured patient lasting between 30 and 74 minutes. This service involves direct patient care and medical decision making to stabilize the patient. |
210 | $171 | $1,470 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
179 | $128 | $776 |
| Echocardiogram, transthoracic An ultrasound of the heart that uses color to show blood flow, rate, direction, and valve function. |
141 | $158 | $1,120 |
| Sedation by physician, initial 15 minutes Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older. |
79 | $10 | $275 |
| Telephone medical discussion, 21-30 minutes A telephone conversation with a physician lasting between 21 and 30 minutes. This code covers the time spent discussing medical matters over the phone. |
62 | $74 | $885 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
60 | $123 | $865 |
| Ultrasound guidance for blood vessel access Use of ultrasound imaging to help locate and access a blood vessel. This guidance assists healthcare providers in performing procedures such as inserting IV lines or drawing blood. |
49 | $11 | $80 |
| Evaluation of implantable heart and blood vessel monitoring system This procedure involves checking the function and data of an implanted device used to monitor heart and blood vessel activity. |
41 | $45 | $255 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while an electrocardiogram is monitored under physician supervision. |
39 | $17 | $120 |
| Exercise or drug-induced heart stress test with ECG A heart stress test performed using exercise or medication while monitoring the electrocardiogram, with physician review of the results. |
39 | $11 | $80 |
| EKG interpretation and report A standard electrocardiogram test that records the heart's electrical activity using at least 12 leads. The service includes a professional interpretation of the results and a written report. |
37 | $7 | $45 |
| Implantable defibrillator system check A check of the implanted defibrillator device to ensure it is functioning correctly. This evaluation covers single, dual, or multiple lead systems. |
36 | $61 | $355 |
| Pacemaker programming, dual lead system Adjustment and configuration of a dual-lead pacemaker device to ensure proper operation and settings. |
35 | $64 | $385 |
| Pacemaker system evaluation Assessment of a pacemaker device, including single, dual, multiple lead, or leadless systems. |
33 | $48 | $265 |
| Cardiac catheterization | 32 | $211 | $1,835 |
| Continuous ECG monitoring, up to 30 days Continuous heart rhythm monitoring for up to 30 days, including professional review and reporting of the results. |
30 | $21 | $145 |
| 30-day continuous ECG with patient-triggered event transmission and review This procedure involves continuous electrocardiogram monitoring for up to 30 days, including the transmission of patient-triggered events. A healthcare professional reviews the data and provides a report. |
28 | $711 | $3,830 |
| Transesophageal echocardiogram An ultrasound of the heart performed using a probe inserted into the esophagus to obtain detailed images of heart structures and function. |
19 | $81 | $580 |
| New patient office visit, complex (60-74 min) | 19 | $148 | $1,095 |
| Echocardiogram, transthoracic An ultrasound test that uses sound waves to create images of the heart's blood flow, valves, and chambers. |
18 | $13 | $100 |
| Echocardiogram with color Doppler An ultrasound of the heart that uses color imaging to visualize blood flow, measure flow rate, and assess valve function. |
18 | $2 | $20 |
| Coronary stent placement A procedure to insert a stent into a coronary artery or its branch to keep it open, using balloon dilation during the process. |
16 | $412 | $3,115 |
| Follow-up heart ultrasound An ultrasound of the heart performed to monitor or reassess a previously identified condition or treatment progress. |
16 | $20 | $140 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
4.0% high complexity
2.3% medium
93.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$7,877
Total received (2018-2024)
Avg $1,125/year across 7 years
Top 32% in CA for cardiovascular disease
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
36
Companies
325
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$7,877 (100.0%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$491
2023
$939
2022
$1,961
2021
$672
2020
$1,285
2019
$1,021
2018
$1,509
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$193
Boston Scientific Corporation
$151
Philips North America LLC
$62
Medtronic, Inc.
$34
Abbott Laboratories
$33
Kestra Medical Technology Services, Inc.
$18
Top 3 companies account for 82.7% of 2024 payments
All-time payments by company (2018-2024) ›
ABIOMED
$1,105
Penumbra, Inc.
$930
Abbott Laboratories
$922
ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)
$810
Boston Scientific Corporation
$809
Novartis Pharmaceuticals Corporation
$734
AstraZeneca Pharmaceuticals LP
$258
E.R. Squibb & Sons, L.L.C.
$243
Merck Sharp & Dohme LLC
$236
Gilead Sciences, Inc.
$204
PFIZER INC.
$200
Medtronic, Inc.
$172
SANOFI-AVENTIS U.S. LLC
$140
Janssen Pharmaceuticals, Inc
$129
Kiniksa Pharmaceuticals, Ltd.
$123
BIOTRONIK INC.
$93
Cardiovascular Systems Inc.
$83
Acist Medical Systems, Inc.
$76
Kestra Medical Technology Services, Inc.
$65
Philips North America LLC
$62
CVRx, Inc.
$57
Terumo Medical Corporation
$57
Amarin Pharma Inc.
$43
Boehringer Ingelheim Pharmaceuticals, Inc.
$38
Amgen Inc.
$37
Regeneron Healthcare Solutions, Inc.
$34
Bard Peripheral Vascular, Inc.
$31
Lantheus Medical Imaging, Inc.
$28
Relypsa, Inc.
$28
Merck Sharp & Dohme Corporation
$25
Esperion Therapeutics, Inc.
$23
Lexicon Pharmaceuticals, Inc.
$22
Philips Electronics North America Corporation
$19
W. L. Gore & Associates, Inc.
$18
Medtronic Vascular, Inc.
$12
Astellas Pharma US Inc
$11
Top 3 companies account for 37.5% of all-time payments
Associated products mentioned in payments ›
(5044) MCOT · (P77) Azurion 7 M20 · Arcalyst · Assure WCD · BIOMONITOR · BRILINTA · Barostim Neo System · CAMZYOS · CARDIOFORM Septal Occluder · CHANTIX · CVI Systems · CoreValve Evolut · DEFINITY · Diamondback Peripheral · ELIQUIS · ENTRESTO · FARXIGA · Glidesheath · HD-IVUS · Impella · Indigo System · Inpefa · JARDIANCE · LEQVIO · LEXISCAN · LIFESTENT · LUX-Dx Insertable Cardiac Monitor · LifeVest · MICRA · MITRACLIP · MULTAQ · Merlin Connectivity and Remote · Micra · Mitra Clip system · NEXLETOL · PRALUENT · PRALUENT ALIROCUMAB INJECTION · Repatha · RotarexS 6 F x 135 cm · VERQUVO · VYNDAQEL · Vascepa · Veltassa · WATCHMAN · XARELTO · XIENCE SKYPOINT
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Cardiologists within 10 mi
118
Per 100K population
5.4
County median income
$82,184
Nearest hospital
KAISER FOUNDATION HOSPITAL FONTANA/ONTARIO
5.6 mi
5.6 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Qasqas is a mixed practice specialist, with above-average Medicare volume (top 10% in CA), with low-engagement industry engagement, with 18 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Qasqas experienced with hospital follow-up visit, moderate complexity?
Based on Medicare claims data, Dr. Qasqas performed 2,874 hospital follow-up visit, moderate complexity services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Qasqas receive payments from pharmaceutical companies?
Yes. Dr. Qasqas received a total of $7,877 from 36 companies across 325 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Qasqas's costs compare to other cardiologists in Rancho Cucamonga?
Dr. Qasqas's average Medicare payment per service is $80. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Qasqas) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Cardiologists in Rancho Cucamonga
Browse cardiologists in Rancho Cucamonga ranked by procedure volume and transparency data.
Highest volume
Top Cardiologists in CA
Cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Cardiologists in CA
Which CA cardiologists receive the most from drug and device companies.
By company
ABIOMED Payments to Doctors
See all physicians who received payments from ABIOMED.
By company
Penumbra, Inc. Payments to Doctors
See all physicians who received payments from Penumbra, Inc.
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology